These success, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the concept of focusing on ACKR3 as a singular solution to modulate the opioid method, which could open new therapeutic avenues for opioid-similar disorders. Conolidine promises to become a https://jamesb814hfb5.wikirecognition.com/user